Np mrd loader

Record Information
Version2.0
Created at2023-12-21 12:01:20 UTC
Updated at2024-09-03 04:18:39 UTC
NP-MRD IDNP0332268
Natural Product DOIhttps://doi.org/10.57994/1463
Secondary Accession NumbersNone
Natural Product Identification
Common NameCompound 13a
DescriptionCompound 13a belongs to the class of organic compounds known as 7,9'-epoxylignans. These are lignans that contain the 7,9'-epoxylignan skeleton, which consists of a tetrahydrofuran that carries a phenyl group, a methyl group, and a benzyl group at the 2-, 3-, 4-position, respectively. Compound 13a was first documented in 2022 (PMID: 35489222). Based on a literature review a significant number of articles have been published on Compound 13a (PMID: 39311818) (PMID: 39047608) (PMID: 38797442) (PMID: 37722267) (PMID: 37379240) (PMID: 37121107).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC33H38O10
Average Mass594.6570 Da
Monoisotopic Mass594.24650 Da
IUPAC Name(S)-[(3R,4S,5R)-4-[(acetyloxy)methyl]-5-(3,4-dimethoxyphenyl)oxolan-3-yl](3,4-dimethoxyphenyl)methyl (2R)-2-methoxy-2-phenylacetate
Traditional Name(S)-[(3R,4S,5R)-4-[(acetyloxy)methyl]-5-(3,4-dimethoxyphenyl)oxolan-3-yl](3,4-dimethoxyphenyl)methyl (2R)-2-methoxy-2-phenylacetate
CAS Registry NumberNot Available
SMILES
[H][C@@]1(CO[C@@H](C2=CC(OC)=C(OC)C=C2)[C@]1([H])COC(C)=O)[C@H](OC(=O)[C@H](OC)C1=CC=CC=C1)C1=CC=C(OC)C(OC)=C1
InChI Identifier
InChI=1S/C33H38O10/c1-20(34)41-18-24-25(19-42-30(24)22-12-14-26(36-2)28(16-22)38-4)31(23-13-15-27(37-3)29(17-23)39-5)43-33(35)32(40-6)21-10-8-7-9-11-21/h7-17,24-25,30-32H,18-19H2,1-6H3/t24-,25+,30+,31-,32-/m1/s1
InChI KeyGAAGPAPKKCIDKB-FQNMNJODSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
COSY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental)halkiku@keio.jpKeio UniversityHaruhisa Kikuchi2024-05-14View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental)halkiku@keio.jpKeio UniversityHaruhisa Kikuchi2024-05-14View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as 7,9'-epoxylignans. These are lignans that contain the 7,9'-epoxylignan skeleton, which consists of a tetrahydrofuran that carries a phenyl group, a methyl group, and a benzyl group at the 2-, 3-, 4-position, respectively.
KingdomOrganic compounds
Super ClassLignans, neolignans and related compounds
ClassFuranoid lignans
Sub ClassTetrahydrofuran lignans
Direct Parent7,9'-epoxylignans
Alternative Parents
Substituents
  • 7,9p-epoxylignan
  • Fatty alcohol ester
  • Benzyloxycarbonyl
  • Benzylether
  • Phenoxy compound
  • Methoxybenzene
  • Phenol ether
  • Anisole
  • Fatty acid ester
  • Alkyl aryl ether
  • Fatty acyl
  • Benzenoid
  • Dicarboxylic acid or derivatives
  • Monocyclic benzene moiety
  • Tetrahydrofuran
  • Carboxylic acid ester
  • Oxacycle
  • Organoheterocyclic compound
  • Ether
  • Dialkyl ether
  • Carboxylic acid derivative
  • Organic oxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP4.05ChemAxon
pKa (Strongest Basic)-3.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area107.98 ŲChemAxon
Rotatable Bond Count15ChemAxon
Refractivity156.69 m³·mol⁻¹ChemAxon
Polarizability61.9 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Zhang R, Su K, Yang L, Duan H, Tang L, Tang M, Zhao M, Ye N, Cai X, Jiang X, Li N, Peng J, Zhang X, Tang L, Qiu Q, Chen L, Wu W, Hu J, Ma L, Ye H: Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease. J Med Chem. 2024 Sep 23. doi: 10.1021/acs.jmedchem.4c01395. [PubMed:39311818 ]
  2. Liu E, Chen Y, Qin M, Yue K, Sun S, Jiang Y, Li X: Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia. Eur J Med Chem. 2024 Oct 5;276:116663. doi: 10.1016/j.ejmech.2024.116663. Epub 2024 Jul 18. [PubMed:39047608 ]
  3. Perina M, Borzsei R, Henrietta Agoston, Hlogyik T, Poor M, Rigo R, Ozvegy-Laczka C, Batta G, Hetenyi C, Vojackova V, Jorda R, Mernyak E: Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates. Eur J Pharm Sci. 2024 Aug 1;199:106813. doi: 10.1016/j.ejps.2024.106813. Epub 2024 May 24. [PubMed:38797442 ]
  4. Namballa HK, Decker AM, Dorogan M, Gudipally A, Goclon J, Harding WW: Fluoroalkoxylated C-3 and C-9 (S)-12-bromostepholidine analogues with D1R antagonist activity. Bioorg Chem. 2023 Dec;141:106862. doi: 10.1016/j.bioorg.2023.106862. Epub 2023 Sep 12. [PubMed:37722267 ]
  5. Elkady H, El-Adl K, Sakr H, Abdelraheem AS, Eissa SI, El-Zahabi MA: Novel promising benzoxazole/benzothiazole-derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis. Arch Pharm (Weinheim). 2023 Sep;356(9):e2300097. doi: 10.1002/ardp.202300097. Epub 2023 Jun 28. [PubMed:37379240 ]
  6. Cao Z, Zhang J, Guo M, Shao B, Wei X, Li S, Wang P, Zhai X: Discovery of novel phenyl triazole analogs as TRK/ALK dual inhibitors with prospective antitumor effects. Bioorg Chem. 2023 Jul;136:106563. doi: 10.1016/j.bioorg.2023.106563. Epub 2023 Apr 25. [PubMed:37121107 ]
  7. Astrain-Redin N, Talavera I, Moreno E, Ramirez MJ, Martinez-Saez N, Encio I, Sharma AK, Sanmartin C, Plano D: Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds. Antioxidants (Basel). 2023 Jan 6;12(1):139. doi: 10.3390/antiox12010139. [PubMed:36671001 ]
  8. Lee JH, Shin JE, Kim W, Jeong P, Kim MJ, Oh SJ, Lee HJ, Park HW, Han SY, Kim YC: Discovery of indirubin-3'-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia. Eur J Med Chem. 2022 Jul 5;237:114356. doi: 10.1016/j.ejmech.2022.114356. Epub 2022 Apr 21. [PubMed:35489222 ]
  9. Li Y, Qi Y, Fang Y, Gao H, Zhang H: Design, Synthesis, and Biological Evaluation of 4-Arylamino Pyrimidine Derivatives as FAK Inhibitors and Tumor Radiotracers. Mol Pharm. 2022 Jul 4;19(7):2471-2482. doi: 10.1021/acs.molpharmaceut.2c00180. Epub 2022 Apr 28. [PubMed:35481371 ]
  10. Zhao J, Li Y, Ma J, Liu J, Xiao R, Wang L, Li P, He Y, Qian F, Zhang A, Sun ZL, Ding C: Synthesis and pharmacological validation of fluorescent diarylsulfonylurea analogues as NLRP3 inhibitors and imaging probes. Eur J Med Chem. 2022 Jul 5;237:114338. doi: 10.1016/j.ejmech.2022.114338. Epub 2022 Apr 4. [PubMed:35436667 ]